LabPulse.com

Lab News

Natera launches new test for kidney rejection
September 9, 2021 -- Natera has launched Prospera with Quantification, a new cell-free DNA test for kidney rejection that works without the need for prior donor or recipient genotyping. Read More

AACC to offer onsite COVID testing at annual meeting
September 8, 2021 -- The American Association for Clinical Chemistry (AACC) will offer free onsite COVID-19 testing at its annual meeting, which is being held September 26-30 in Atlanta. Read More

Illumina, Merck partner on HRD test
September 8, 2021 -- Illumina and Merck have agreed to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Read More

LumiraDx launches COVID surveillance test in U.S.
September 3, 2021 -- LumiraDx is launching a portable, rapid onsite COVID-19 surveillance test in the U.S., the company announced. Read More

Sectra reports Q1 increase on early U.S. deliveries
September 3, 2021 -- Sectra reported "unusually" strong financial numbers for the first quarter of the 2021 fiscal year, based on earlier-than-expected product deliveries to the U.S. Read More

Agilent enters digital pathology with Visiopharm deal
September 2, 2021 -- Agilent Technologies and Visiopharm have signed a worldwide distribution agreement that allows Agilent to co-market Visiopharm's portfolio of digital pathology software. The deal represents Agilent's entry into digital pathology. Read More

NGS is transforming diagnostics, but is it right for everyone?
September 1, 2021 -- As clinical laboratories embrace genetic testing to improve their diagnosis of disease, many are turning to next-generation sequencing (NGS) to speed diagnosis. But does every diagnostic laboratory have the volume to justify investing in NGS technology, where hardware and software costs can run several hundred thousands of dollars at a minimum? Read More

Cancer diagnoses still lower a year into COVID-19 pandemic
September 1, 2021 -- Fully a year into the COVID-19 pandemic, the rate of cancer diagnosis in the U.S. remained sharply below the rate before the outbreak, according to a study published August 31 in JAMA Network Open. The findings indicate that there may be a wave of advanced cancers coming in the near future. Read More

Thermo Fisher, AstraZeneca to develop NGS companion diagnostics
September 1, 2021 -- Thermo Fisher Scientific and AstraZeneca plan to co-develop companion diagnostics based on next-generation sequencing (NGS) to support targeted therapies. Read More

AACC strengthens COVID rules for annual meeting
August 31, 2021 -- The American Association for Clinical Chemistry (AACC) has strengthened attendance rules for its upcoming annual meeting in Atlanta and is now requiring all attendees to be fully vaccinated for COVID-19, according to an August 30 email from AACC President Dr. Stephen Master, PhD. Read More

« prev 1 2 3 4…166 next »

Webinars/Videos